WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $6,557,000 | -4.7% | 194,756 | -0.8% | 0.97% | -11.5% |
Q3 2014 | $6,877,000 | +5.4% | 196,369 | -1.1% | 1.10% | +18.8% |
Q2 2014 | $6,527,000 | -18.4% | 198,620 | -8.5% | 0.93% | -10.1% |
Q1 2014 | $7,999,000 | -4.5% | 217,001 | -0.6% | 1.03% | -7.8% |
Q4 2013 | $8,376,000 | +10.7% | 218,228 | -20.9% | 1.12% | +4.7% |
Q3 2013 | $7,563,000 | – | 276,028 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coupland Cardiff Asset Management LLP | 448,361 | $15,096,000 | 21.12% |
Sloane Robinson LLP | 107,400 | $3,616,000 | 6.28% |
Sensato Investors LLC | 327,754 | $11,035,000 | 3.26% |
Grandeur Peak Global Advisors, LLC | 388,810 | $13,091,000 | 2.94% |
GRATRY & Co LLC | 205,800 | $7,899,000 | 2.59% |
THOMAS WHITE INTERNATIONAL LTD | 464,926 | $15,654,000 | 2.15% |
COMGEST GLOBAL INVESTORS S.A.S. | 1,819,980 | $61,279,000 | 1.87% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,169,686 | $39,383,000 | 1.64% |
Ninety One North America, Inc. | 133,372 | $4,491,000 | 1.32% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 87,560 | $2,948,000 | 1.27% |